retatrutide trial results news today This is exciting. 👀 The TRIUMPH-4 for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far beyond Lilly orforglipron oral GLP-1 phase

Transforming Lives, One Step at a Time Keep reading Mons Pubis Fat Loss on GLP-1s: The Pubic Area Change Nobody Mentions One change that surprises people on GLP-1 medications rarely comes up in conversation: the mons pubis, the soft fat pad over the pubic bone, How to Adjust Weight Loss Goals on GLP-1 Medications Adjust weight goals on GLP-1 meds by tracking body composition and labs, optimizing protein, activity, sleep, and working with your provider on dosing

Keerie, A

* Dica prtica: use azeite extra virgem na salada ou acrescente uma poro de castanhas no lanche da tarde ou ceia

Glucagon's Effects on Nerves: Glucagon receptors exist throughout the nervous system Activation affects nerve cell metabolism May alter nerve excitability or signal transmission Could disrupt normal sensory processing Supporting Evidence: Dysesthesia only occurs with retatrutide (which has glucagon component) Dose-dependent (higher glucagon activation = more dysesthesia) Not seen in Phase 2 at lower doses (less glucagon effect) Theory 2: Rapid Weight Loss and Nerve Changes Retatrutide produces the fastest, most substantial weight loss of any obesity medication 28.7% at 68 weeks (TRIUMPH-4) and 28.3% at 80 weeks (TRIUMPH-1)

Many people wonder about this after seeing ads for these products